LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives $112.60 Consensus Target Price from Brokerages
LeMaitre Vascular, Inc. (NASDAQ:LMAT – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the eight ratings firms that are presently covering the company, MarketBeat reports. Three investment analysts have rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to […]
25 May 05:34 · The Cerbat Gem